Syneron Medical Ltd. To Report First Quarter 2016 Financial Results On May 19, 2016
IRVINE, Calif., April 27, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, May 19, 2016. The earnings release will be available on Syneron's website at www.investors.syneron.com.
Syneron management will host a conference call and a live webcast at 8:30 a.m. (ET) on the same day. A question & answer session will follow management's discussion of events in the first quarter 2016.
Investors and analysts may participate in the conference call using the following dial-in numbers:
US (toll free): (877) 280-2296
International: (646) 254-3367
The conference passcode for both is 7925493.
Investors and other interested parties can also access a live webcast of the conference call through the Investor Relations page on Syneron's website at www.investors.syneron.com. Please log-in at least 10 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the webcast will be available within 24 hours on the Company's website.
About Syneron Candela:
Syneron Candela is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company has a wide portfolio of trusted, leading products including UltraShape, VelaShape, GentleLase, VBeam Perfecta, PicoWay, Profound and elos Plus.
Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Candela are located in Israel. Syneron Candela also has R&D and manufacturing operations in the U.S. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
For additional information, please visit http://www.syneron-candela.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/syneron-medical-to-report-first-quarter-2016-financial-results-on-may-19-2016-300258355.html
SOURCE Syneron Medical Ltd.